Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asunaprevir + Daclatasvir in chronic hepatitis C genotype 1b (China)
CTR20132226Phase 3Active
- Sponsor
- Bristol Myers Squibb
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of asunaprevir, daclatasvir in chronic hepatitis C (CHC), sponsored by Bristol Myers Squibb. Started Feb 2014; status: active.
02
Drugs
asunaprevirdaclatasvir
03
Conditions
chronic hepatitis C (CHC)
Beyond the preview
Go deeper on CTR20132226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132226.